1.     Identification of the source plants in honey by microscopic analysis of pollens. HKBU Faculty Research Grant. 2015. HK$143,000.

2.     Correlating microscopic characteristics and biologically active components for evaluating the quality of Chinese medicinal materials. Hong Kong General Research Fund. 2015. HK$661,659.

3.     Oral bioavailability of polysaccharides: an exploration of TLRs/Dectin-mediated phagocytosis to Ganoderma glucan GSP-2 by intestinal macrophages in vitro and in vivo. Hong Kong General Research Fund. 2015. HK$ 870,855.

4.     Discovery of potential components attributed to pro-fibrotic activity of Aconitum carmichaeli Debx.. HKBU Faculty Research Grant. 2014. HK$127,500.

5.     Standardization on the Nomenclatures of Chinese Medicinal Materials and Decoction Pieces Sold in Hong Kong. Innovation and Technology Fund. 2014. HK$ 416,000.

6.      Clarifying the Lingnan Medicinal Materials of Compendium of Materia Medica (Ben Cao Gang Mu). National Natural Science Foundation of China. 2014. RMB$ 700,000.

7.      HKCMMS Phase IX: Chemical assay of Polygonati Rhizoma and Homalomenae Rhizoma. Dept. of Health, HKSAR. 2014. HK$ 741,405.

8.     Anticancer Mechanism of Alpiniae Officinarum Rhizoma against Gastric Cancer: from the Combinational Treatment of Curcumin and Quercetin. HKBU-FRG. 2014. HK$ 90,000.

9.     Scientific elucidation of macroscopic identification of Bupleuri Radix by profiling tissue-specific chemicals. National Natural Science Foundation of China. 2014. RMB230,000.

10.  Structural Modification and Biological Studies of the Antitumor Natural Products Miliusanes as Novel Cancer Therapeutic Agents. Hong Kong General Research Fund. 2014. HK$ 914,985.

11.   Exhibition at InnoCarnival 2013: Matching Towards Modern Chinese Medicine: Conservation of Rare Chinese Medicines Resources and Exhibition of Modern Chinese Medicine Technology. Innovation and Technology Fund. 2013. HK$ 719,000.

12.  Chemical and Biological Assessment of Herbal Decoction Dangui Buxue Tang using Hedysari Radix instead of Astragali Radix. HKBU-FRG. 2013. HK$ 90,000.

13.   HKCMMS Phase VIII: Chemical assay of Hedysari Radix and Saussureae Involucratae Herba. Dept. of Health, HKSAR. 2013. HK$ 290,000.

14.   Discovery of Aryl Naphthalide Lignans as Potential Anti-HIV Inhibitors from the Medicinal Plant Justicia gendarussa. Hong Kong General Research Fund. 2013. HK$1,268,250.

15.   In Vivo Evaluation of Antitumor Efficacy of Plant-Derived Novel Natural Products Miliusanes. 2013. HK$1,284,701.

16.  Laser Microdissection Analysis: Linking morphology and biochemistry to assess the quality of Chinese medicinal materials. Hong Kong General Research Fund. 2012. HK$ 843,720.

17.   HKCMMS Phase VII: Chemical assay of Dendrobii Caulis and Dendrobii Officinalis Caulis. Dept. of Health, HKSAR. 2012. HK$ 260,000.

18.   Platform Development for Quality Control Standards of Processed Chinese Materia Medica (Decoction Pieces) in the Hong Kong Market. Innovation and Technology Fund. 2012. HK$2,719,324.

19.   HKCMMS Phase VI: Collection of CMM samples and Chemical assay of Carthami Flos. Dept. of Health, HKSAR. 2011. HK$ 251,000.

20.  Histochemical Analysis of Chinese Medicinal Materials by Combining Laser Microdissection with LC-MS. National Natural Science Foundation of China. 2011. RMB$ 650,000.

21.  Mapping and extraction of active components in the stem of Sinomenium Acutum by combining laser microdissection with LC-MS. HKBU-FRG. 2011. HK$ 120,000.

22.  Active Components Screening and Metabolism Study of Tibetan “Xuelianhua” (Saussurea laniceps). Research Grants Council (GRF). 2011. HK$ 751,019.

23.   HKCMMS Phase VI: Collection of CMM samples and Chemical assay of Carthami Flos. Dept. of Health, HKSAR. 2011. HK$ 251,000.

24.  Active Components Screening and Metabolism Study of Dragon’s Blood (Daemonorops Draco). HKBU-FRG. 2011. HK$ 120,000.

25.  HKCMMS Phase V(A): Chemical assay of Perillae Caulis and Tribuli Fructus and HKCMMS Phase V(B): Chemical assay of Gleditsiae Spina and Piperis Longi Fructus. HKBU-FRG. 2011. HK$ 396,800.

26.  Active Components Screening and Metabolism Study of Tibetan “Xuelianhua” (Saussurea laniceps). HKBU-FRG. 2010. HK$ 127,500.





Copyright © 2015 Research Centre for Standardization of Chinese Medicines